Is tamoxifen a risk factor for retinal vaso-occlusive disease?

Retina

Volumn 25, Issue 4, 2005, Pages 523-526

  Gorin, Michael B ^a,b,f   Costantino, Joseph P ^b   Kulacoglu, Destan N ^a   Demirci, F Yesim K ^a   Wickerham, D Lawrence ^d,e   Fisher, Bernard ^c,d   Wolmark, Norman ^d,e  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d NSABP Foundation Inc   (United States)

^e DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; GLAUCOMA; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; RETINA BLOOD VESSEL OCCLUSION; RISK FACTOR; SMOKING;

AGED; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; RETINAL ARTERY OCCLUSION; RETINAL VEIN OCCLUSION; RETINAL VESSELS; RISK FACTORS; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TAMOXIFEN;

EID: 20344404961     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006982-200506000-00023     Document Type: Article

References (9)

1. Reddy P, Chow MS. Safety and efficacy of antiestrogens for prevention of breast cancer. Am J Health Syst Pharm 2000;57:1315-1322.
2. Gorin MB, Day R, Costantino JP, et al. Long-term tamoxifen citrate use and potential ocular toxicity. Am J Ophthalmol 1998;125:493-501.
3. Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study [comment]. J Natl Cancer Inst 1998;90:1371-1388.
4. Nayfield SG, Gorin MB. Tamoxifen-associated eye disease. A review. J Clin Oncol 1996;14:1018-1026.
5. The Eye Disease Case-Control Study Group. Risk factors for central retinal vein occlusion. Arch Ophthalmol 1996;114:545-554.
6. Mitchell P, Smith W, Chang A. Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains Eye Study. Arch Ophthalmol 1996;114:1243-1247.
7. Kirwan JF, Tsaloumas MD, Vinall H, et al. Sex hormone preparations and retinal vein occlusion. Eye 1997;11:53-56.
8. Love RR, Surawicz TS, Williams EC. Antithrombin III level, fibrinogen level, and platelet count changes with adjuvant tamoxifen therapy. Arch Intern Med 1992;152:317-320.
9. Schlich B, Heidrich H, Keuch R, et al. Occlusion of finger arteries and thrombotic angiopathy of the retina during adjuvant tamoxifen therapy of a mammary carcinoma. Dtsch Med Wochenschr 1997;122:783-786.